Hodgkin lymphoma, leukemia survivor: Targeted therapy clinical trial put me in remission
By the time I got to MD Anderson in March 2021, I’d already been through two cancer diagnoses, three relapses, six types of chemotherapy and two stem cell transplants. I was only 21.
But I’d exhausted all the treatment options near my home in Lithuania. I was worried I wouldn’t be able to watch my sisters’ children grow up, see the world or care about some of the same things my peers did.
Then, I heard about a targeted therapy...